|
Market Closed -
Warsaw S.E.
11:55:50 2026-08-13 EDT
|
5-day change | 1st Jan Change | ||
| 136.60 PLN | -0.15% |
|
+0.74% | +0.29% |
| 05-27 | Scope Fluidics says Bacteromic granted U.S. patent 'microfluidic chip' | RE |
| 05-15 | Scope Fluidics Q1 net loss at 13.5 million zlotys | RE |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | - | - | 198.2 | +44.88% | 1 | ||||
| 25.07 | -0.71% | 7 | ||||||
| 57.82 | +29.41% | 11 | ||||||
| 9.222 | +36.83% | 9 | ||||||
| 52.33 | +10.62% | 6 | ||||||
| - | - | 48.3 | +19.73% | 1 | ||||
| - | 45,500 | +42.41% | 2 | |||||
| 7.3 | +26.3% | 5 | ||||||
| 8.333 | +85.19% | 3 | ||||||
| Average | 5,100.73 | +32.74% | 5 | ||||||
| Weighted average by Cap. | 2,695.1 | +21.08% | 7 |
- Stock Market
- Stocks
- SCP Stock
- Sector Scope Fluidics S.A.
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
